Mutant KRAS G12V-specific TCR Transduced T Cell Therapy for Advanced Solid Tumor
Clinical trial NCT05933668 · UNKNOWN
Trial details
- NCT number
- NCT05933668
- Sponsor
- Peking University
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-01
- Primary completion
- 2024-07-01
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.